EUVIMEDOpdag EUVIMED
Open access · CC BY-NC 4.0

Activation of the Carotid Body by Kappa Opioid Receptors Mitigates Fentanyl-Induced Respiratory Depression

Aktivierung des Karotiskörpers durch Kappa-Opioidrezeptoren mindert die durch Fentanyl induzierte Atemdepression

Ying-Jie Peng, Jayasri Nanduri, Ning Wang, Zheng Xie, Aaron P Fox, Nanduri R Prabhakar

Function · 2025-05-19 · 6 (3)

DOI: 10.1093/function/zqaf020 ↗

Auf einen Blick

Bei Ratten aktivierte Fentanyl den Karotiskörper zunächst und führte dann zu Atemdepression. Ein KOR-Agonist milderte die Atemdepression, wenn der Karotiskörper intakt war.

Fragestellung

Welche Wirkung haben Fentanyl und Sufentanil auf die Aktivität des Karotiskörpers und auf die Atmung?

Methode

Tierexperimentelle Studie mit unanästhesierten Ratten; zusätzlich RNA-Sequenzierung und Immunhistochemie an Karotiskörpern.

Ergebnisse

Fentanyl und Sufentanil steigerten die afferente Nervenaktivität des Karotiskörpers und die [Ca2+]i in Glomuszellen. KOR-Agonist und Fentanyl aktivierten den Karotiskörper; ein KOR-Antagonist blockierte dies. Fentanyl senkte die Atmung nach initialer Stimulation; KOR-Agonist milderte diese Wirkung.

Schlussfolgerung der Autor:innen

Die Ergebnisse zeigen eine bisher nicht beschriebene Aktivierung von Karotiskörper-Afferenzen durch Fentanyl über KORs und deuten darauf hin, dass KOR-Agonisten die zentrale Atemdepression durch Opioide abschwächen könnten.

Kernaussagen

  • Fentanyl und Sufentanil aktivierten Karotiskörper-Afferenzen
  • KOR-Agonist wirkte atemstimulierend ohne Atemhemmung
  • Kombination mit KOR-Agonist minderte Fentanyl-Atemdepression

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Journal article in Function, published online on 2025-05-16. Written by Ying-Jie Peng and 5 co-authors. Institution: Institute for Integrative Physiology and Center for Systems Biology of O2 Sensing, The University of Chicago, Chicago, IL 60637, USA. Major MEDLINE topics: Receptors, Opioid, kappa, Fentanyl, Carotid Body, Respiratory Insufficiency. Cited 10 times so far (Crossref); 47 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: NHLBI NIH HHS, NIH HHS, National Institutes of Health.

Auf einen BlickAbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Previous studies reported that opioids depress breathing by inhibiting respiratory neural networks in the brainstem. The effects of opioids on sensory inputs regulating breathing are less studied. This study examined the effects of fentanyl and sufentanil on carotid body neural activity, a crucial sensory regulator of breathing. Both opioids stimulated carotid body afferent nerve activity and increased glomus cell [Ca2+]i levels. RNA sequencing and immunohistochemistry revealed a high abundance of κ opioid receptors (KORs) in carotid bodies, but no µ or δ opioid receptors. A KOR agonist, like fentanyl, stimulated carotid body afferents, while a KOR antagonist blocked carotid body activation by fentanyl and KOR agonist. In unanesthetized rats, fentanyl initially stimulated breathing, followed by respiratory depression. A KOR agonist stimulated breathing without respiratory inhibition, and this effect was absent in carotid body-denervated rats. Combining fentanyl with a KOR agonist attenuated respiratory depression in rats with intact carotid body but not in carotid body-denervated rats. These findings highlight previously uncharacterized activation of carotid body afferents by fentanyl via KORs as opposed to depression of brainstem respiratory neurons by µ opioid receptors and suggest that KOR agonists might counteract the central depressive effects of opioids on breathing.

Subjects

MeSH terms (MEDLINE)

Receptors, Opioid, kappaFentanylCarotid BodyRespiratory InsufficiencyAnalgesics, OpioidAnimalsRatsMaleRats, Sprague-Dawley

Author keywords

arterial chemo receptorsimmunocytochemistrykappa opioid receptorsopioid-induced respiratory depressionpre-Bötzinger complex

Substances

Receptors, Opioid, kappaFentanylAnalgesics, Opioid

Authors and institutions

  • Institute for Integrative Physiology and Center for Systems Biology of O2 Sensing, The University of Chicago, Chicago, IL 60637, USA.
  • Department Anesthesia and Critical Care, The University of Chicago, Chicago, IL 60637, USA.
  • Department Pharmacological and Physiological Sciences, The University of Chicago, Chicago, IL 60637, USA.

Funding

  • NHLBI NIH HHS
  • NIH HHS
  • National Institutes of Health

Cite

APA

Peng, Y. J., Nanduri, J., Wang, N., Xie, Z., Fox, A. P., & Prabhakar, N. R. (2025). Activation of the Carotid Body by Kappa Opioid Receptors Mitigates Fentanyl-Induced Respiratory Depression. Function, 6(3). https://doi.org/10.1093/function/zqaf020

Vancouver

Peng YJ, Nanduri J, Wang N, Xie Z, Fox AP, Prabhakar NR. Activation of the Carotid Body by Kappa Opioid Receptors Mitigates Fentanyl-Induced Respiratory Depression. Function. 2025;6(3). doi:10.1093/function/zqaf020

BibTeX
@article{Peng2025,
  author = {Peng, Ying-Jie and Nanduri, Jayasri and Wang, Ning and Xie, Zheng and Fox, Aaron P and Prabhakar, Nanduri R},
  title = {Activation of the Carotid Body by Kappa Opioid Receptors Mitigates Fentanyl-Induced Respiratory Depression},
  journal = {Function},
  year = {2025},
  volume = {6},
  number = {3},
  doi = {10.1093/function/zqaf020}
}
Start for free →